Showing results (1-10 of 127) with videos related to
Sort By:
Pageof 13
Plos Medicine|January 20, 2026
Missing tissue, missing data: Resolving brain volume loss caused by anti-amyloid therapiesFrancesca Alves, Scott AytonNeurology|March 27, 2023
Accelerated Brain Volume Loss Caused by Anti-β-Amyloid Drugs: A Systematic Review and Meta-analysisFrancesca Alves, Pawel Kalinowski, Scott AytonSignal Transduction and Targeted Therapy|January 2, 2025
In defence of ferroptosisFrancesca Alves, Darius Lane, Triet Phu Minh Nguyen, et al.Trends in Neurosciences|July 22, 2025
Triggering ferroptosis in neurodegenerative diseasesTriet P M Nguyen, Francesca Alves, Darius J R Lane, et al.Journal of Neurochemistry|March 6, 2026
Iron Depletion in the Substantia Nigra of Children With Prenatal Alcohol ExposureFrancesca Alves, Amir Fazollahi, Pawel Kalinowski, et al.Biomed Research International|February 15, 2014
Nigral iron elevation is an invariable feature of Parkinson's disease and is a sufficient cause of neurodegenerationScott Ayton, Peng LeiNature Reviews. Neuroscience|May 19, 2025
Neuroferroptosis in health and diseasesPeng Lei, Tara Walker, Scott AytonJournal of Neurochemistry|July 23, 2021
Iron reduces the propagation of pathological α-synuclein: An Editorial Highlight for "Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils" on page 554Yu-Jie Guo, Scott Ayton, Peng LeiNeurobiology of Disease|February 23, 2020
Cerebrospinal fluid ceruloplasmin levels predict cognitive decline and brain atrophy in people with underlying β-amyloid pathologyIbrahima Diouf, Ashley I Bush, Scott Ayton, et al.Pageof 13